Phenolic Diterpenoid Derivatives as Anti-Influenza A Virus Agents
ACS Medicinal Chemistry Letters2015Vol. 6(3), pp. 355–358
Citations Over TimeTop 23% of 2015 papers
Abstract
A series of diterpenoid derivatives based on podocarpic acid were synthesized and evaluated as anti-influenza A virus agents. Several of the novel podocarpic acid derivatives exhibited nanomolar activities against an H1N1 influenza A virus (A/Puerto Rico/8/34) that was resistant to two anti-influenza drugs, oseltamivir and amantadine. This class of compounds inhibits the influenza virus by targeting the viral hemagglutinin-mediated membrane fusion. These results indicated that podocarpic acid derivatives may serve as potential drug candidates to fight drug-resistant influenza A virus infections.
Related Papers
- → Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro(2010)174 cited
- → Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)(2009)137 cited
- → Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand(2009)31 cited
- → The influence of oseltamivir carboxylate and oseltamivir on hemagglutinin inhibition and microneutralization test(2008)3 cited
- → A Cost-Effectiveness Analysis Comparing Oseltamivir, Amantadine, and Ribavirin Combination Antiviral Therapy Versus Oseltamivir Monotherapy for Influenza(2024)